Zenas BioPharma, Inc.
ZBIO
$19.16
-$1.24-6.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.16% | -24.80% | 48.58% | 740.77% | 516.93% |
| Total Receivables | -40.00% | -- | -- | 70.00% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 121.03% | -36.12% | 15.97% | 140.36% | 86.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -93.08% |
| Total Current Assets | -1.34% | -24.67% | 47.72% | 700.42% | 495.15% |
|
|
|||||
| Total Current Assets | -1.34% | -24.67% | 47.72% | 700.42% | 495.15% |
| Net Property, Plant & Equipment | 16.74% | 57.25% | 51.70% | 50.65% | 17.26% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.41% | 51.52% | 10.81% | 51.17% | 74.63% |
| Total Assets | 3.70% | -20.18% | 46.58% | 580.45% | 442.63% |
|
|
|||||
| Total Accounts Payable | -58.50% | -57.27% | -5.11% | 131.96% | 217.57% |
| Total Accrued Expenses | 38.67% | 58.98% | 49.77% | 45.47% | 130.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 42.04% | 60.94% | 60.53% | 75.97% | 41.19% |
| Total Finance Division Other Current Liabilities | -44.08% | -- | -- | -99.72% | -29.90% |
| Total Other Current Liabilities | -44.08% | -- | -- | -99.72% | -29.90% |
| Total Current Liabilities | 9.35% | 19.15% | 36.15% | 61.98% | 146.33% |
|
|
|||||
| Total Current Liabilities | 9.35% | 19.15% | 36.15% | 61.98% | 146.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.21% | -- | 1,435.71% | 138.35% | -15.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 146.04% | 185.45% | 36.65% | -3.91% | 31.26% |
|
|
|||||
| Common Stock & APIC | 43.98% | 3.89% | 9,673.88% | 12,415.80% | 14,962.54% |
| Retained Earnings | -97.51% | -56.72% | -59.76% | -63.04% | -68.14% |
| Treasury Stock & Other | -132.99% | -227.78% | -190.38% | 90.54% | 424.32% |
| Total Common Equity | -22.50% | -45.35% | 182.98% | 212.60% | 238.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -22.50% | -45.35% | 182.98% | 212.60% | 238.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.50% | -45.35% | 48.99% | 11,902.28% | 1,182.41% |
|
|
|||||